Title |
Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma
|
---|---|
Published in |
Respiratory Research, April 2014
|
DOI | 10.1186/1465-9921-15-46 |
Pubmed ID | |
Authors |
Seil Sagar, Mary E Morgan, Si Chen, Arjan P Vos, Johan Garssen, Jeroen van Bergenhenegouwen, Louis Boon, Niki A Georgiou, Aletta D Kraneveld, Gert Folkerts |
Abstract |
Asthma is estimated to affect as many as 300 million people worldwide and its incidence and prevalence are rapidly increasing throughout the world, especially in children and within developing countries. Recently, there has been a growing interest in the use of potentially beneficial bacteria for allergic diseases. This study is aimed at exploring the therapeutic effects of long-term treatment with two different beneficial bacterial strains (Bifidobacterium breve M-16 V and Lactobacillus rhamnosus NutRes1) and a glucocorticoid (budesonide), as a reference treatment, on inflammatory response in a murine model for chronic allergic asthma. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 23% |
Venezuela, Bolivarian Republic of | 1 | 8% |
Switzerland | 1 | 8% |
Canada | 1 | 8% |
United States | 1 | 8% |
Unknown | 6 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 101 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 17% |
Student > Bachelor | 14 | 14% |
Researcher | 13 | 13% |
Student > Master | 10 | 10% |
Student > Postgraduate | 9 | 9% |
Other | 15 | 15% |
Unknown | 23 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 19% |
Agricultural and Biological Sciences | 13 | 13% |
Immunology and Microbiology | 12 | 12% |
Biochemistry, Genetics and Molecular Biology | 12 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Other | 12 | 12% |
Unknown | 28 | 28% |